.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Johnson and Johnson
Citi
Julphar
McKesson
Teva
QuintilesIMS
Express Scripts
McKinsey

Generated: December 16, 2017

DrugPatentWatch Database Preview

Fougera Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA, and when can generic versions of FOUGERA drugs launch?

FOUGERA has one hundred and nineteen approved drugs.

There is one US patent protecting FOUGERA drugs.

There are seventeen patent family members on FOUGERA drugs in fifteen countries and twenty-three supplementary protection certificates in ten countries.

Summary for Fougera

International Patents:17
US Patents:1
Tradenames:56
Ingredients:48
NDAs:119
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms IncNYSTATINnystatinSUSPENSION;ORAL062517-001Jun 7, 1984AARXNoNo► Subscribe► Subscribe► Subscribe
FougeraTRIPLE SULFAtriple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)TABLET;VAGINAL088463-001Jan 3, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Fougera PharmsPAMINE FORTEmethscopolamine bromideTABLET;ORAL008848-002Mar 25, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Fougera PharmsBETAMETHASONE DIPROPIONATEbetamethasone dipropionateCREAM, AUGMENTED;TOPICAL076215-001Dec 9, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
FougeraNYSTATINnystatinTABLET;VAGINAL062459-001Nov 9, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Fougera PharmsAMCINONIDEamcinonideLOTION;TOPICAL076329-001Nov 6, 2002RXNoYes► Subscribe► Subscribe► Subscribe
FougeraFLUOCINONIDEfluocinonideSOLUTION;TOPICAL072934-001Feb 27, 1995ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera PharmsTEMOVATE Eclobetasol propionateCREAM;TOPICAL020340-001Jun 17, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Fougera PharmsACLOVATEalclometasone dipropionateCREAM;TOPICAL018707-001Dec 14, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
FougeraTIMOLOL MALEATEtimolol maleateSOLUTION/DROPS;OPHTHALMIC074668-001Mar 25, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Fougera

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera PharmsSOLARAZEdiclofenac sodiumGEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera PharmsCUTIVATEfluticasone propionateOINTMENT;TOPICAL019957-001Dec 14, 1990► Subscribe► Subscribe
Fougera PharmsACLOVATEalclometasone dipropionateCREAM;TOPICAL018707-001Dec 14, 1982► Subscribe► Subscribe
Fougera PharmsSOLARAZEdiclofenac sodiumGEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera PharmsTEMOVATEclobetasol propionateOINTMENT;TOPICAL019323-001Dec 27, 1985► Subscribe► Subscribe
Fougera PharmsSOLARAZEdiclofenac sodiumGEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera PharmsSOLARAZEdiclofenac sodiumGEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera PharmsTEMOVATEclobetasol propionateCREAM;TOPICAL019322-001Dec 27, 1985► Subscribe► Subscribe
Fougera PharmsSOLARAZEdiclofenac sodiumGEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera PharmsSOLARAZEdiclofenac sodiumGEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for FOUGERA drugs

Drugname Dosage Strength Tradename Submissiondate
diclofenac sodiumTopical Gel3%SOLARAZE12/16/2009
fluticasone propionateLotion0.05%CUTIVATE7/28/2008

International Patent Family for Fougera Drugs

Country Document Number Estimated Expiration
United Kingdom9823036► Subscribe
European Patent Office1123101► Subscribe
Hungary0104251► Subscribe
Israel142471► Subscribe
Czech Republic20011419► Subscribe
Japan2002528418► Subscribe
New Zealand510949► Subscribe
China1176659► Subscribe
Norway20011911► Subscribe
Turkey200101109► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Fougera Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0021Belgium► SubscribePRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
C0038France► SubscribePRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
269Luxembourg► SubscribePRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
C/GB08/026United Kingdom► SubscribePRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080111; UK EU/1/07/434/002 20080111; UK EU/1/07/434/003 20080111
C/GB10/012United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
C0014France► SubscribePRODUCT NAME: FLUTICASONE FLUORATE; REG. NO/DATE: EU/1/07/434/001 20080111
C0002Belgium► SubscribePRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622
C0024France► SubscribePRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218
C/GB99/003United Kingdom► SubscribePRODUCT NAME: IMIQUIMOD; REGISTERED: UK EU/1/98/080/001 19980918
13/044Ireland► SubscribePRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Federal Trade Commission
Baxter
Cipla
Johnson and Johnson
McKinsey
Accenture
Farmers Insurance
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot